-
Track & Monitor
Monthly Mining Industry Deals Review – August 2018
GlobalData's “Monthly Mining Industry Deals Review – August 2018” report is an essential source of data and trend analysis on M&A (mergers, acquisitions, and asset transactions), in the mining industry. The report provides detailed comparative monthly data on the number of deals and their value, sub-divided into deal types, by status, by region, and country. The report also highlights top buyers and sellers by region in addition to top announced and completed deals by value globally.
-
Product Insights
Cholestasis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Cholestasis Global Clinical Trials Review, H2, 2018" provides an overview of Cholestasis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholestasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018" provides an overview of Bronchopulmonary Dysplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchopulmonary Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the NASH market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Immuno-oncology Development Trends and Opportunities
Immuno-oncology (IO) is the treatment of cancer with therapies that stimulate or suppress the body’s own immune system. Several distinct modalities of IO therapy exist, including bispecific T-cell engaging monoclonal antibodies, cellular immunotherapy and adoptive cellular therapy, cancer vaccines, checkpoint modulating monoclonal antibodies, and oncolytic viruses. This report provides an overview of current clinical development trends for IO within the 8MM (France, Germany, Italy, Spain, UK, US, Japan, China), including a history of recent approvals, indications currently being explored for...
-
Product Insights
Binge Eating Disorder Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Binge Eating Disorder Global Clinical Trials Review, H2, 2018" provides an overview of Binge Eating Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Binge Eating Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Arteriovenous Fistula Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Arteriovenous Fistula Global Clinical Trials Review, H2, 2018" provides an overview of Arteriovenous Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriovenous Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Competitor Landscape: Lupus
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Lupus market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Alzheimer’s Disease: Dynamic Market Forecast to 2026
Alzheimer’s Disease (AD) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the AD space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact the projected market forecast.
-
Sector Analysis
Crohn’s Disease: Dynamic Market Forecast to 2026
Crohn’s disease is a form of inflammatory bowel disease, which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn's disease and ulcerative colitis. In Crohn’s disease, chronic inflammation may affect any part of the gastrointestinal tract from the mouth to the anal area; however, Crohn’s disease occurs most commonly in the lower part of the small intestine (ileum) and in the large intestine. The pathophysiology of Crohn’s disease is complex, as the disease is characterized by recurring...